Cargando…

Cost-effectiveness of two screening strategies based on Chinese diabetes risk score for pre-diabetes in China

OBJECTIVE: Studies have shown that screening for pre-diabetes mellitus (pre-DM) is essential to prevent type 2 diabetes mellitus (T2DM). This study evaluates the cost-effectiveness of two screening strategies that apply the Chinese Diabetes Risk Score (CDRS) to screen for pre-DM in China. METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Jingjing, Yao, Qiang, Lin, Yidie, Sun, Yue, Zhang, Baiyang, Hu, Meijing, Zhang, Jing, Zhao, Ningxuan, Pei, Jiao, Liu, Zhonghua, Zhu, Cairong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747942/
https://www.ncbi.nlm.nih.gov/pubmed/36530668
http://dx.doi.org/10.3389/fpubh.2022.1018084
_version_ 1784849716059570176
author Hao, Jingjing
Yao, Qiang
Lin, Yidie
Sun, Yue
Zhang, Baiyang
Hu, Meijing
Zhang, Jing
Zhao, Ningxuan
Pei, Jiao
Liu, Zhonghua
Zhu, Cairong
author_facet Hao, Jingjing
Yao, Qiang
Lin, Yidie
Sun, Yue
Zhang, Baiyang
Hu, Meijing
Zhang, Jing
Zhao, Ningxuan
Pei, Jiao
Liu, Zhonghua
Zhu, Cairong
author_sort Hao, Jingjing
collection PubMed
description OBJECTIVE: Studies have shown that screening for pre-diabetes mellitus (pre-DM) is essential to prevent type 2 diabetes mellitus (T2DM). This study evaluates the cost-effectiveness of two screening strategies that apply the Chinese Diabetes Risk Score (CDRS) to screen for pre-DM in China. METHODS: A Markov microsimulation model was conducted from a social perspective, and the input parameters were obtained from published literature or publicly available data. Two screening strategies for pre-DM based on CDRS were built and compared with the control group to determine the cost-effective strategy. The screening strategy of the control group was screening for pre-DM by fasting plasma glucose (FPG) test in adults undergoing annual health examination and no screening in adults without an annual health examination (status quo). Two screening strategies were strategy 1: screening for pre-DM using CDRS in all adults (including with or without an annual health examination); and strategy 2: supplemental self-screening for pre-DM using CDRS in adults without an annual health examination, based on the status quo. We focus on the cumulative prevalence of T2DM and the incremental cost-effectiveness ratio which signifies the cost per case of T2DM prevented. We also evaluated the cost-effectiveness from the health system perspective. One-way and probabilistic sensitivity analyses were conducted to verify the robustness of the results. RESULTS: The costs a case of T2DM prevented for strategy 1 compared with the control group and strategy 2 were $299.67 (95% CI 298.88, 300.46) and $385.89 (95% CI 381.58, 390.20), respectively. In addition, compared with the control group, the cost of strategy 2 to prevent a case of T2DM was $272.23 (95% CI 271.50, 272.96). CONCLUSIONS: Screening for pre-DM using CDRS in all adults was the most cost-effective health policy. We suggest that medical institutions replace FPG with CDRS for pre-DM screening; at the same time, self-screening for pre-DM using CDRS is widely promoted among adults without an annual health examination. There were still some disputes about how CDRS is included in the health examination projects, so strategy 2 should be considered as an alternative screening strategy. Findings provide a reference for the application of the CDRS in pre-DM screening and contribute to T2DM prevention.
format Online
Article
Text
id pubmed-9747942
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97479422022-12-15 Cost-effectiveness of two screening strategies based on Chinese diabetes risk score for pre-diabetes in China Hao, Jingjing Yao, Qiang Lin, Yidie Sun, Yue Zhang, Baiyang Hu, Meijing Zhang, Jing Zhao, Ningxuan Pei, Jiao Liu, Zhonghua Zhu, Cairong Front Public Health Public Health OBJECTIVE: Studies have shown that screening for pre-diabetes mellitus (pre-DM) is essential to prevent type 2 diabetes mellitus (T2DM). This study evaluates the cost-effectiveness of two screening strategies that apply the Chinese Diabetes Risk Score (CDRS) to screen for pre-DM in China. METHODS: A Markov microsimulation model was conducted from a social perspective, and the input parameters were obtained from published literature or publicly available data. Two screening strategies for pre-DM based on CDRS were built and compared with the control group to determine the cost-effective strategy. The screening strategy of the control group was screening for pre-DM by fasting plasma glucose (FPG) test in adults undergoing annual health examination and no screening in adults without an annual health examination (status quo). Two screening strategies were strategy 1: screening for pre-DM using CDRS in all adults (including with or without an annual health examination); and strategy 2: supplemental self-screening for pre-DM using CDRS in adults without an annual health examination, based on the status quo. We focus on the cumulative prevalence of T2DM and the incremental cost-effectiveness ratio which signifies the cost per case of T2DM prevented. We also evaluated the cost-effectiveness from the health system perspective. One-way and probabilistic sensitivity analyses were conducted to verify the robustness of the results. RESULTS: The costs a case of T2DM prevented for strategy 1 compared with the control group and strategy 2 were $299.67 (95% CI 298.88, 300.46) and $385.89 (95% CI 381.58, 390.20), respectively. In addition, compared with the control group, the cost of strategy 2 to prevent a case of T2DM was $272.23 (95% CI 271.50, 272.96). CONCLUSIONS: Screening for pre-DM using CDRS in all adults was the most cost-effective health policy. We suggest that medical institutions replace FPG with CDRS for pre-DM screening; at the same time, self-screening for pre-DM using CDRS is widely promoted among adults without an annual health examination. There were still some disputes about how CDRS is included in the health examination projects, so strategy 2 should be considered as an alternative screening strategy. Findings provide a reference for the application of the CDRS in pre-DM screening and contribute to T2DM prevention. Frontiers Media S.A. 2022-11-30 /pmc/articles/PMC9747942/ /pubmed/36530668 http://dx.doi.org/10.3389/fpubh.2022.1018084 Text en Copyright © 2022 Hao, Yao, Lin, Sun, Zhang, Hu, Zhang, Zhao, Pei, Liu and Zhu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Hao, Jingjing
Yao, Qiang
Lin, Yidie
Sun, Yue
Zhang, Baiyang
Hu, Meijing
Zhang, Jing
Zhao, Ningxuan
Pei, Jiao
Liu, Zhonghua
Zhu, Cairong
Cost-effectiveness of two screening strategies based on Chinese diabetes risk score for pre-diabetes in China
title Cost-effectiveness of two screening strategies based on Chinese diabetes risk score for pre-diabetes in China
title_full Cost-effectiveness of two screening strategies based on Chinese diabetes risk score for pre-diabetes in China
title_fullStr Cost-effectiveness of two screening strategies based on Chinese diabetes risk score for pre-diabetes in China
title_full_unstemmed Cost-effectiveness of two screening strategies based on Chinese diabetes risk score for pre-diabetes in China
title_short Cost-effectiveness of two screening strategies based on Chinese diabetes risk score for pre-diabetes in China
title_sort cost-effectiveness of two screening strategies based on chinese diabetes risk score for pre-diabetes in china
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747942/
https://www.ncbi.nlm.nih.gov/pubmed/36530668
http://dx.doi.org/10.3389/fpubh.2022.1018084
work_keys_str_mv AT haojingjing costeffectivenessoftwoscreeningstrategiesbasedonchinesediabetesriskscoreforprediabetesinchina
AT yaoqiang costeffectivenessoftwoscreeningstrategiesbasedonchinesediabetesriskscoreforprediabetesinchina
AT linyidie costeffectivenessoftwoscreeningstrategiesbasedonchinesediabetesriskscoreforprediabetesinchina
AT sunyue costeffectivenessoftwoscreeningstrategiesbasedonchinesediabetesriskscoreforprediabetesinchina
AT zhangbaiyang costeffectivenessoftwoscreeningstrategiesbasedonchinesediabetesriskscoreforprediabetesinchina
AT humeijing costeffectivenessoftwoscreeningstrategiesbasedonchinesediabetesriskscoreforprediabetesinchina
AT zhangjing costeffectivenessoftwoscreeningstrategiesbasedonchinesediabetesriskscoreforprediabetesinchina
AT zhaoningxuan costeffectivenessoftwoscreeningstrategiesbasedonchinesediabetesriskscoreforprediabetesinchina
AT peijiao costeffectivenessoftwoscreeningstrategiesbasedonchinesediabetesriskscoreforprediabetesinchina
AT liuzhonghua costeffectivenessoftwoscreeningstrategiesbasedonchinesediabetesriskscoreforprediabetesinchina
AT zhucairong costeffectivenessoftwoscreeningstrategiesbasedonchinesediabetesriskscoreforprediabetesinchina